Epoch Investment Partners’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-221,260
Closed -$6.86M 308
2019
Q1
$6.86M Sell
221,260
-173,069
-44% -$4.62M 0.03% 231
2018
Q4
$9.32M Sell
394,329
-439,664
-53% -$12M 0.04% 217
2018
Q3
$32.3M Sell
833,993
-98,100
-11% -$3.53M 0.12% 146
2018
Q2
$31.2M Buy
932,093
+160,754
+21% +$5.72M 0.1% 151
2018
Q1
$27.9M Buy
771,339
+28,627
+4% +$992K 0.1% 157
2017
Q4
$23.6M Buy
+742,712
New +$25.4M 0.08% 173

Other funds holding LMAT

Epoch Investment Partners's LMAT Position: Q2 2019 in Review

Epoch Investment Partners sold out of LeMaitre Vascular (LMAT) in Q2 2019, closing a stake of 221,260 shares — an estimated $6.86M sold.

Epoch Investment Partners first reported a position in LMAT in Q4 2017 and held it in 6 quarters. The position peaked at $32.3M in Q3 2018. 150 funds tracked by Wall St. Rank hold LMAT as of Q2 2019.

  • Epoch Investment Partners reported no remaining LeMaitre Vascular position as of Q2 2019 after selling out during the quarter.
  • Epoch Investment Partners sold 221,260 LeMaitre Vascular shares in Q2 2019, an estimated $6.86M.
  • Epoch Investment Partners first reported a position in LeMaitre Vascular in Q4 2017 and held it in 6 quarters.
  • Epoch Investment Partners's LeMaitre Vascular position peaked at $32.3M in Q3 2018.
  • 150 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2019.

Based on Epoch Investment Partners's 13F filing for Q2 2019, filed 13 Aug 2019.